Rationale and Design of a Randomized Controlled Trial Evaluating Whole Muscle Exercise Training Effects in Outpatients with Pulmonary Arterial Hypertension (WHOLEi+12)
Background and Aims
Physical exercise is an important component in the management of pulmonary artery hypertension (PAH). The aim of this randomized controlled trial (RCT) is to determine the effects of an 8-week intervention combining muscle resistance, aerobic and inspiratory pressure load exercises in PAH outpatients.
The RCT will be conducted from September 2015 to September 2016 following the recommendations of the Consolidated Standards of Reported Trials (CONSORT), with a total sample size of n ≥ 48 (≥24 participants/group). We will determine the effects of the intervention on: (i) skeletal-muscle power and mass (primary end points); and (ii) NT-proBNP, cardiopulmonary exercise testing variables (VO2peak, ventilatory equivalent for CO2 at the anaerobic threshold (VE/VCO2 at the AT), end-tidal pressure of CO2 at the anaerobic threshold (PETCO2 at the AT), 6-min walking distance (6MWD), maximal inspiratory pressure (PImax), health-related quality of life (HRQoL), objectively-assessed spontaneous levels of physical activity, and safety (secondary end points).
Conclusions and Perspectives
This trial will provide insight into biological mechanisms of the disease and indicate the potential benefits of exercise in PAH outpatients, particularly on muscle power.
KeywordsResistance exercise Pulmonary disease VO2peak NT-proBNP Cardio-pulmonary exercise testing
We acknowledge to Powerbreathe Spain, Biocorp Europa, Andoain, Basque Country, Spain for the kind donation of devices for inspiratory muscle training. Research by A.L. is funded by Fondo de Investigaciones Sanitarias (grant #PS12/00194) and Fondos FEDER.
Compliance with Ethical Standards
Conflict of Interest
The authors declare they have no financial competing interests.
- 3.McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119:2250–94.CrossRefPubMedGoogle Scholar
- 6.British Cardiac Society G, Medical Practice C, approved by the British Thoracic S, the British Society of R. Recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001;86 Suppl 1:I1-13Google Scholar
- 35.Santalla A, Munguia-Izquierdo D, Brea-Alejo L, et al. Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits. Front Aging Neurosci. 2015;6:334.Google Scholar
- 40.Standardization of spirometry--1987 update. Official statement of American Thoracic Society. Respir Care 1987;32:1039–1060Google Scholar
- 43.Alonso J, Regidor E, Barrio G, et al. Population reference values of the Spanish version of the health questionnaire SF-36. Med Clin (Barc). 1998;111:410–6.Google Scholar